Decreased expression of interleukin-36α correlates with poor prognosis in hepatocellular carcinoma (Q39092640)

9 September 2017

title

Decreased expression of interleukin-36α correlates with poor prognosis in hepatocellular carcinoma (English)

1 reference

9 September 2017

Qiu-Zhong Pan

1 reference

9 September 2017

Ke Pan

1 reference

9 September 2017

Jing-Jing Zhao

1 reference

9 September 2017

Ju-Gao Chen

1 reference

9 September 2017

Jian-Jun Li

1 reference

9 September 2017

Lin Lv

1 reference

9 September 2017

Dan-Dan Wang

1 reference

9 September 2017

Hai-Xia Zheng

1 reference

9 September 2017

Shan-Shan Jiang

1 reference

9 September 2017

Xiao-Fei Zhang

1 reference

9 September 2017

Jian-Chuan Xia

1 reference

9 September 2017

publication date

6 September 2013

1 reference

Cancer Immunology, Immunotherapy

9 September 2017

published in

1 reference

9 September 2017

1 reference

9 September 2017

1 reference

9 September 2017

page(s)

1675-1685

1 reference

Two novel IL-1 family members, IL-1 delta and IL-1 epsilon, function as an antagonist and agonist of NF-kappa B activation through the orphan IL-1 receptor-related protein 2

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1471-1

IL-1F5, -F6, -F8, and -F9: a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1471-1

Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1471-1

Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1471-1

Expression of interleukin (IL)-1 family members upon stimulation with IL-17 differs in keratinocytes derived from patients with psoriasis and healthy donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1471-1

IL-1RL2 and its ligands contribute to the cytokine network in psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1471-1

Hepatocellular carcinoma: epidemiology, risk factors, and screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1471-1

Hepatocellular carcinoma: the need for progress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1471-1

Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1471-1

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1471-1

Interleukin-2 gene expression is a new biological prognostic marker in hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1471-1

Expression of interleukins-23 and 27 leads to successful gene therapy of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1471-1

Survivin expression quantified by Image Pro-Plus compared with visual assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1471-1

Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1471-1

Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1471-1

Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1471-1

Interleukin-1--a major pleiotropic cytokine in tumor-host interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1471-1

The role of interleukin 1 in growth and metastasis of human cancer xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1471-1

Differential effects of IL-1 alpha and IL-1 beta on tumorigenicity patterns and invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1471-1

Innate immunity mediated by the cytokine IL-1 homologue 4 (IL-1H4/IL-1F7) induces IL-12-dependent adaptive and profound antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1471-1

Reduced tumorigenicity of fibrosarcomas which constitutively generate IL-1 alpha either spontaneously or following IL-1 alpha gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1471-1

Gene transfer of a hybrid interleukin-1β gene to B16 mouse melanoma recruits leucocyte subsets and reduces tumour growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1471-1

Interleukin-18: biology and role in the immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1471-1

10.1007/S00262-013-1471-1

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference